Diagnostic error and wrong lab result settlement amounts in 2026 depend on whether the error was a laboratory processing mistake, a radiology misinterpretation, a pathology misclassification, or a clinical failure to order appropriate tests -- and the medical harm that resulted from the delay or incorrect treatment.
This site is operated by Mustafa Bilgic, an individual based in Adiyaman, Turkiye. NOT a licensed attorney, NOT a law firm, NOT legal advice.
Address: Malazgirt No: 225, 02000 Adiyaman, Turkiye
Email: [email protected]
This page does not publish fake verdicts or testimonials. Dollar examples are hypothetical worksheets only.
A diagnostic error settlement amount depends on the type of error, the disease or condition that was missed or misidentified, and the medical consequences of the delay. The National Academies of Sciences, Engineering, and Medicine published a landmark 2015 report, "Improving Diagnosis in Health Care," which concluded that most people will experience at least one diagnostic error in their lifetime and that diagnostic errors contribute to approximately 10 percent of patient deaths. AHRQ (Agency for Healthcare Research and Quality) identifies diagnostic safety as a top patient safety priority. A 2014 study published in BMJ Quality and Safety estimated that approximately 12 million adults in outpatient settings experience a diagnostic error each year in the United States, and about half of those errors have the potential to cause harm.
Diagnostic error claims are among the most common and highest-value medical malpractice claims. They encompass a broad range of failures: a radiologist who misreads a mammogram and misses a breast cancer, a pathologist who misidentifies a tissue biopsy, a laboratory that mislabels a blood specimen causing a patient to receive the wrong diagnosis, and a physician who fails to order an indicated test based on presenting symptoms.
| Error type | How it occurs | Typical defendant | Relative claim value |
|---|---|---|---|
| Radiology misinterpretation | Radiologist misses fracture, tumor, or hemorrhage on imaging | Radiologist; radiology group; hospital | High: delayed treatment of cancer, stroke, fracture |
| Pathology misclassification | Tissue sample misidentified as benign or malignant | Pathologist; laboratory | Very high: unnecessary surgery or untreated cancer |
| Specimen mislabeling | Blood, urine, or tissue specimen labeled with wrong patient ID | Phlebotomist; lab technician; hospital | Moderate to high: wrong treatment based on wrong results |
| Reagent or equipment failure | Lab equipment produces inaccurate results due to calibration error | Laboratory; equipment manufacturer | Variable: depends on how many patients affected |
| Failure to follow up on results | Abnormal result generated but never communicated to patient or physician | Ordering physician; hospital EHR system; clinic | High: directly delays diagnosis and treatment |
| Clinical diagnostic failure | Physician fails to order indicated tests or misinterprets clinical presentation | Treating physician; hospital | Variable: depends on missed condition and outcome |
| False positive leading to unnecessary treatment | Incorrect positive result leads to unnecessary surgery, chemotherapy, or radiation | Laboratory; pathologist; treating physician | High: physical harm from unnecessary treatment plus emotional distress |
The central difficulty in diagnostic error litigation is proving causation -- specifically, that the delayed or incorrect diagnosis caused the patient's harm. The defense will argue that the underlying disease would have progressed regardless of when it was diagnosed, or that the treatment outcome would have been the same even with earlier diagnosis. This is where the "loss of chance" doctrine becomes critical. Some states allow plaintiffs to recover damages proportional to the reduction in their chance of a better outcome. For example, if a delayed lung cancer diagnosis reduced the patient's five-year survival probability from 60 percent to 25 percent, states recognizing the loss of chance doctrine would allow recovery proportional to the 35 percent reduction. Not all states recognize this doctrine, and the methods for calculating damages under it vary.
Clinical laboratories in the United States are regulated under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, administered by CMS. CLIA establishes quality standards for proficiency testing, quality control, personnel qualifications, and quality assurance. A laboratory that fails to meet CLIA standards -- for example, by using improperly calibrated equipment, employing undertrained technicians, or failing to participate in required proficiency testing -- may face enhanced negligence liability. CLIA violations can serve as evidence that the laboratory's standard of care fell below the legal requirement, similar to how OSHA violations support workplace injury claims.
A patient presents with rectal bleeding. A colonoscopy biopsy is taken and sent to a pathology laboratory. The pathologist misinterprets the tissue sample as benign when it contains adenocarcinoma. Fourteen months later, the patient is re-evaluated and correctly diagnosed with Stage III colorectal cancer. Treatment now requires surgery, chemotherapy, and radiation ($185,000 versus the estimated $62,000 for Stage I treatment). Lost wages during extended treatment: $34,000. Non-economic damages at a multiplier of 3 for the advancement from an early-stage to late-stage cancer and the associated reduction in prognosis: $657,000.
Gross trial value: $219,000 (economic) plus $657,000 (non-economic) equals approximately $876,000. Liability probability is estimated at 70 percent (pathology misinterpretation supported by expert re-review of the original slides). Risk-adjusted value: approximately $613,000 before fees, costs, and liens. In a loss-of-chance jurisdiction, damages might be adjusted proportionally to the reduction in survival probability.
A growing category of diagnostic error involves EHR (electronic health record) systems that fail to route abnormal test results to the ordering physician, bury critical results in data overload, or allow results to be filed without physician review. These system-level failures can create liability for the hospital, the clinic, and potentially the EHR vendor. The Joint Commission has identified failures in the test result management process as a significant patient safety concern. Plaintiffs in these cases must establish that the EHR design or implementation contributed to the diagnostic delay -- a theory that may involve both medical and technology expert testimony.
According to AHRQ, the most commonly missed diagnoses in malpractice claims include cancer (particularly breast, lung, and colorectal), vascular events (stroke, heart attack, pulmonary embolism), and infections (sepsis, meningitis). Lab-specific errors include mislabeled specimens, reagent failures, and reporting errors.
Cancer misdiagnosis is one specific type of diagnostic error. Diagnostic errors broadly include laboratory processing mistakes (mislabeled specimens, equipment calibration failures), radiology misinterpretation (missed fractures, overlooked masses on imaging), pathology errors (misclassifying tissue samples), and clinical diagnostic failures (failing to order appropriate tests).
Potentially liable parties include the laboratory and its pathologists or technicians, the ordering physician if they failed to follow up on abnormal or unexpected results, the hospital if institutional policies contributed to the error, and the electronic health record vendor if a software defect caused a result to be misrouted or mislabeled.
The loss of chance doctrine allows a plaintiff to recover damages even when the misdiagnosis did not definitely cause the harm, but rather reduced the chance of a better outcome. For example, if a delayed cancer diagnosis reduced the patient's five-year survival rate from 70 percent to 40 percent, some states allow recovery proportional to that lost chance. Not all states recognize this doctrine.
Clinical laboratories in the United States are regulated under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, administered by CMS. CLIA establishes quality standards for laboratory testing to ensure accuracy, reliability, and timeliness of test results. CLIA violations can support a negligence claim.
Potentially yes. A false positive that leads to unnecessary treatment (surgery, chemotherapy, radiation) can support a malpractice claim for the physical harm from unnecessary treatment and the associated emotional distress. Even if no unnecessary treatment occurred, some jurisdictions allow claims for the severe emotional distress of being told you have a serious disease you do not have.
No. This page is operated by Mustafa Bilgic, a non-attorney individual operator. It is educational research only.